PAM
GILD icon

PartnerRe Asset Management’s Gilead Sciences GILD Stock Holding History

PartnerRe Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,220
Closed -$847K – 163
2016
Q1 		$847K Sell
9,220
-498
-5% -$44.9K 0.43% 35
2015
Q4 		$983K Sell
9,718
-16,843
-63% -$1.75M 0.51% 32
2015
Q3 		$2.61M Buy
26,561
+15
+0.1% +$1.67K 0.44% 36
2015
Q2 		$3.11M Sell
26,546
-5,010
-16% -$547K 0.58% 32
2015
Q1 		$3.1M Sell
31,556
-574
-2% -$58.3K 0.52% 37
2014
Q4 		$3.03M Buy
32,130
+4,463
+16% +$462K 0.5% 40
2014
Q3 		$2.94M Sell
27,667
-4,986
-15% -$488K 0.58% 35
2014
Q2 		$2.71M Sell
32,653
-4,522
-12% -$352K 0.48% 43
2014
Q1 		$2.63M Buy
37,175
+264
+0.7% +$20.7K 0.44% 49
2013
Q4 		$2.77M Sell
36,911
-2,100
-5% -$146K 0.48% 48
2013
Q3 		$2.45M Sell
39,011
-5,002
-11% -$299K 0.41% 50
2013
Q2 		$2.26M Buy
+44,013
New +$2.29M 0.36% 51

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PartnerRe Asset Management's GILD Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 9,220 shares — an estimated $847K sold.

PartnerRe Asset Management first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $3.11M in Q2 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 9,220 Gilead Sciences shares in Q2 2016, an estimated $847K.
  • PartnerRe Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Gilead Sciences position peaked at $3.11M in Q2 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.